A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing

This publication has 15 references indexed in Scilit:

• Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space
  Radiotherapy and Oncology, 2003
• Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques
  Radiotherapy and Oncology, 2001
• A phase III study on the concurrent use of oral pilocarpine to reduce hyposalivation and mucositis associated with radiation therapy in head and neck cancer patients. Final results of RTOG 97-09
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Quality of life and oral function following radiotherapy for head and neck cancer
  Head & Neck, 1999
• Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue
  Head & Neck, 1997
• In Defense of the Oral Cavity: Structure, Biosynthesis, and Function of Salivary Mucins
  Annual Review of Physiology, 1995
• Oral and dental management of the cancer patient: prevention and treatment of complications
  Supportive Care in Cancer, 1995
• Major salivary gland function in patients with radiation-induced xerostomia: Flow rates and sialochemistry
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Physiological Factors Affecting Salivary Flow Rate, Oral Sugar Clearance, and the Sensation of Dry Mouth in Man
  Journal of Dental Research, 1987